English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 12, 2026

New technique expands noninvasive prenatal genetic screening to nearly 23,000 genes
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

WHO reports global progress and ongoing gaps in safe blood supply
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Malcolm Brenner to lead Houston Methodist Center for Cell and Gene Therapy
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

FDA issues import alert on Dabur India plant after inspection reveals violations
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Researchers at UCSF develop robotic system to study surviving cancer cells
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

India's tuberculosis control strategy shows progress and ongoing challenges
+ Pharmaceuticals
Patient Daily | Jun 12, 2026

Researchers explore peptide strategy to protect brain cells in Parkinson's disease study
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation